Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Osteomalacia is caused by defective bone mineralization, most often from severe or prolonged vitamin D deficiency due to low sunlight exposure, poor diet, malabsorption conditions such as celiac disease or bariatric surgery, or chronic kidney and liver disease. Low phosphate levels, inherited disorders like X-linked hypophosphatemia, certain tumors, and long-term use of medications such as anticonvulsants or antacids containing aluminum can also trigger it. Because the causes range from simple nutritional gaps to genetic and kidney-related conditions, the right treatment depends entirely on which one applies to you. There are several important factors to consider, including risk factors, overlapping symptoms like bone pain and muscle weakness, and when testing is needed, so review the complete details below before drawing conclusions.
If bone pain, muscle weakness, or unexplained fractures are worrying you, a free, instant, online symptom check can help you organize what you are feeling, see which conditions may fit your pattern, and understand what to raise with a clinician, all in a few minutes and without a wait or a bill.
Last reviewed for medical accuracy: 08/18/2026
Osteomalacia is a condition characterized by softening of the bones due to defective bone mineralization. While it shares some features with osteoporosis, osteomalacia involves a failure to lay down sufficient calcium and phosphorus in the bone matrix. Understanding osteomalacia causes is key to prevention, early detection, and treatment.
Healthy bones are built and maintained through a balance of:
When this balance is disturbed—most often because of low levels of vitamin D, calcium, or phosphate—bone mineralization falters, leading to the hallmark “soft” bones of osteomalacia.
Vitamin D Deficiency
Vitamin D is essential for calcium and phosphorus absorption. Deficiency is by far the most common driver of osteomalacia. Causes include:
Malabsorption Syndromes
Conditions that impair the gut’s ability to absorb fat-soluble vitamins (including vitamin D) can lead to osteomalacia:
Kidney Disease
The kidneys convert vitamin D into its active form (calcitriol). Chronic kidney disease (CKD) can hamper this process, causing low active vitamin D levels and, consequently, defective bone mineralization.
Liver Disease
The liver is the first organ to metabolize vitamin D into 25‐hydroxyvitamin D. Liver dysfunction (e.g., cirrhosis, hepatitis) can lower this conversion, reducing overall vitamin D availability.
Phosphate Depletion
Phosphate is as important as calcium in forming strong bone. Causes of low phosphate include:
Medications and Toxins
Rare Genetic Disorders
Though uncommon in adults, inherited conditions such as vitamin D–dependent rickets types I and II affect enzymes or receptors involved in vitamin D metabolism, preventing effective bone mineralization.
Certain populations and behaviors increase the likelihood of developing osteomalacia:
Recognizing your risk factors and monitoring bone health can help you and your healthcare provider take steps before symptoms worsen.
Early on, osteomalacia may cause subtle symptoms or none at all. As the condition progresses, you may notice:
If you experience any combination of bone pain, muscle weakness, or unexplained fractures, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Accurate diagnosis relies on a combination of:
Early detection means earlier treatment, which can prevent serious complications.
Addressing osteomalacia causes typically involves:
With proper treatment, many people experience significant improvement in pain, strength, and bone density within months.
Although osteomalacia often has a gradual onset, certain signs warrant prompt medical attention:
If you have concerns, discuss them with your healthcare provider. A free, online symptom check, using the doctor approved Ubie Symptom Checker, can help you decide when to seek professional care.
Always consult a qualified healthcare professional about any symptoms that could be serious or life-threatening.
(References)
* Munns CF, Shaw N, Kiely M, Specker BL, Thacher TD, Ozono K, Michigami T, Tiosano D, Mughal MZ, Mäkitie O, Ramos-Abad L, Ward L, DiMeglio LA, Atapattu N, Cassinelli H, Braegger C, Pettifor JM, Seth A, Idris HW, Bhatia V, Fu J, Goldberg G, Sävendahl L, Khadgawat R, Pludowski P, Maddock J, Hyppönen E, Oduwole A, Frew E, Aguiar M, Tulchinsky T, Butler G, Högler W. Global Consensus Recommendations on Prevention and Management of Nutritional Rickets. J Clin Endocrinol Metab. 2016 Feb;101(2):394-415. doi: 10.1210/jc.2015-2175. Epub 2016 Jan 8. PMID: 26745253; PMCID: PMC4880117.
* Cianferotti L. Osteomalacia Is Not a Single Disease. Int J Mol Sci. 2022 Nov 28;23(23). doi: 10.3390/ijms232314896. Epub 2022 Nov 28. PMID: 36499221; PMCID: PMC9740398.
* Ito N, Hidaka N, Kato H. The pathophysiology of hypophosphatemia. Best Pract Res Clin Endocrinol Metab. 2024 Mar;38(2):101851. doi: 10.1016/j.beem.2023.101851. Epub 2023 Nov 30. PMID: 38087658.
* Ackah SA, Imel EA. Approach to Hypophosphatemic Rickets. J Clin Endocrinol Metab. 2022 Dec 17;108(1):209-220. doi: 10.1210/clinem/dgac488. PMID: 35981346; PMCID: PMC9759174.
* Schaefer B, Tobiasch M, Wagner S, Glodny B, Tilg H, Wolf M, Zoller H. Hypophosphatemia after intravenous iron therapy: Comprehensive review of clinical findings and recommendations for management. Bone. 2022 Jan;154:116202. doi: 10.1016/j.bone.2021.116202. Epub 2021 Sep 15. PMID: 34534708.
* Wagner SA, Panzer M, Pertler E, Redl S, Saretto M, Schaefer B, Pammer LM, Obholzer L, Troppmair MR, Hess MW, Salvenmoser W, Degenhart G, Grossgut M, Talasz H, Faserl K, Sarg B, Haubner R, Hartmann MA, Blouin S, Petzer V, Gronich-Wondrak P, Kronbichler A, Manzl C, Glodny B, Tilg H, Franke A, Wolf M, Hadjihannas MV, Zoller H. Ferric carboxymaltose increases fracture risk in patients and reduces bone formation in mice with iron deficiency anemia. Blood. 2026 Jul 2;148(1):15-30. doi: 10.1182/blood.2025031806. PMID: 41849242; PMCID: PMC13389865.
* Francis RM, Selby PL. Osteomalacia. Baillieres Clin Endocrinol Metab. 1997 Apr;11(1):145-63. doi: 10.1016/s0950-351x(97)80569-1. PMID: 9222490.
* Rosa J. [Osteomalacia]. Vnitr Lek. 2023 Summer;69(4):254-260. doi: 10.36290/vnl.2023.048. PMID: 37468295.
* Smith R. Asian rickets and osteomalacia. Q J Med. 1990 Sep;76(281):899-901. PMID: 2236475.
* Kruse HP. [Osteomalacia]. Internist (Berl). 1991 Feb;32(2):90-9. PMID: 2032793.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.